13F-HR filed by R Squared Ltd
R Squared Ltd filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-05, with 509 holding rows worth $190,447,284.
- Accession
- 0001896148-26-000004
- Filer
- CIK 1896148
- Filed
- 2026-08-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 509 entries on the cover page, a total value of $190,447,284 stated on the cover page (in dollars after the unit check, H1), rows summing to $190,447,284 with VALUE read as dollars as filed, 13F file number 028-24591. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEW FORTRESS ENERGY INC | 644393100 | COM CL A | 35,884 | $13,030 | dollars as filed | |
| RING ENERGY INC | 76680V108 | COMMON STOCK | 11,992 | $12,951 | dollars as filed | |
| BRC INC A | 05601U105 | COMMON STOCK | 11,504 | $12,770 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 19,786 | $10,212 | dollars as filed | |
| PARAZERO TECHNOLOGIES LTD | M7S13T102 | SHS | 20,433 | $9,939 | dollars as filed | |
| INNOVIZ TECHNOLOGIES LTD | M5R635108 | SHS | 12,568 | $9,567 | dollars as filed | |
| CITIUS PHARMACEUTICALS INC | 17322U306 | COM | 11,033 | $6,670 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 27,745 | $6,270 | dollars as filed | |
| ACCURAY INC DEL | 004397105 | COM | 19,354 | $4,990 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001896148-26-000004 | this filing | 2026-08-05 | acceptance time not in the bulk data set |